HRT Financial’s Arcellx ACLX Stock Holding History

HRT Financial’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,725	Closed	-$706K	–	2209
2023 Q4	$706K	Sell	12,725 -8,290	-39%	-$374K	0.01%	1172
2023 Q3	$754K	Buy	+21,015	New	+$725K	0.01%	1175

Other funds holding ACLX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HRT Financial's ACLX Position: Q1 2024 in Review

HRT Financial sold out of Arcellx (ACLX) in Q1 2024, closing a stake of 12,725 shares — an estimated $706K sold.

HRT Financial first reported a position in ACLX in Q3 2023 and held it in 2 quarters. The position peaked at $754K in Q3 2023. 183 funds tracked by Wall St. Rank hold ACLX as of Q1 2024.

HRT Financial reported no remaining Arcellx position as of Q1 2024 after selling out during the quarter.
HRT Financial sold 12,725 Arcellx shares in Q1 2024, an estimated $706K.
HRT Financial first reported a position in Arcellx in Q3 2023 and held it in 2 quarters.
HRT Financial's Arcellx position peaked at $754K in Q3 2023.
183 funds tracked by Wall St. Rank held Arcellx as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.